Publications by authors named "J Bertolli"
Background: Recovery from SARS CoV-2 infection is expected within 3 months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3 months that are continuous, relapsing and remitting, or progressive. Better understanding of Long COVID illness trajectories could strengthen patient care and support.
View Article and Find Full Text PDFArticle Synopsis
- - The study evaluated the prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) among Kaiser Permanente Northern California patients in the wake of the COVID-19 pandemic, involving nearly 10,000 adults.
- - An estimated 1.67% of participants reported ME/CFS-like illness, with about 14.12% of those cases occurring after a COVID-19 infection, particularly among unvaccinated individuals or those who had COVID-19 early in the pandemic.
- - Despite the findings, the overall impact of COVID-19 on increasing rates of ME/CFS-like illness appeared minimal during the study period, but those identified with the illness experienced significant impairments in multiple areas of functioning
Article Synopsis
- The MCAM study aimed to see if different clinicians recognized myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as the same clinical condition by analyzing data from 465 patients across seven specialized clinics in the U.S.
- Research found minimal significant differences in ME/CFS symptoms and functionalities among patients from various clinics, indicating a possible inherent illness heterogeneity.
- The study suggests that representing data visually (like scatter plots) could better illustrate this variation, and emphasizes the need for more detailed subgroup analyses in future research to enhance understanding and reproducibility of ME/CFS findings.
This study aimed to estimate the incidence rates of post-COVID-19 fatigue and chronic fatigue and to quantify the additional incident fatigue caused by COVID-19. We analyzed electronic health records data of 4,589 patients with confirmed COVID-19 during February 2020-February 2021 who were followed for a median of 11.4 (interquartile range 7.
View Article and Find Full Text PDF